Paul Daly (Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I thank the Vice Chairman. Going back again to the submission, I will quote directly from it: "... in order to protect competition in the market, it is vital that the NVPS as it is being developed provides for the full availability of appropriate generic alternative medicines." Is Mr. Doyle saying that the NVPS is being set up not to include generic medicines? If I am reading this correctly I have two questions on the consequences of same. Mr. Doyle may not know exactly, but how many jobs are there in Ireland in companies that produce such generic medicines? If generic medicines are not going to be accepted, will those companies and jobs be gone in the production of the product?

Going back to the discussion we had earlier about what antiparasitic resistance actually is, in the context of limiting the product on the market if one has a narrower window of choice will this in itself accelerate resistance as opposed to helping the farmer with a bit of diversity to try to avoid antiparasitic resistance?